Auricular point stimulation plus dexamethasone
Sponsors
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions
Nausea and Vomiting Caused by ChemotherapyNausea and Vomiting Caused by Trastuzumab Deruxtecan
Phase 2
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
RecruitingNCT07537699
Start: 2025-11-25End: 2026-11-01Target: 25Updated: 2026-04-17
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Gemcitabine Plus Paclitaxel
RecruitingNCT07537660
Start: 2025-11-25End: 2026-11-01Target: 25Updated: 2026-04-17
Auricular Point Stimulation Plus Dexamethasone for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
RecruitingNCT07537673
Start: 2025-11-25End: 2026-11-01Target: 25Updated: 2026-04-17
Phase 3
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Gemcitabine Combined With Paclitaxel Protein-bound
RecruitingNCT07716228
Start: 2025-12-12End: 2026-12-12Target: 74Updated: 2026-07-21
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Docetaxel Plus Cyclophosphamide
RecruitingNCT07716176
Start: 2025-12-12End: 2026-12-12Target: 74Updated: 2026-07-21
Auricular Point Stimulation Plus Dexamethasone Versus Standard Antiemetic Regimen for Nausea and Vomiting Caused by Trastuzumab Deruxtecan
RecruitingNCT07716189
Start: 2025-12-12End: 2026-12-12Target: 74Updated: 2026-07-21